Percona Announces Speakers, Tutorials and Sponsors for Percona Live Open Source Database Conference Europe 2017
3.8.2017 09:00 | NASDAQ OMX
Early Bird Registration Discount Expires on August 8, 2017, Sponsorships Still Available
RALEIGH, N.C., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today revealed the initial roster of speakers, tutorials and sponsors for Percona Live Open Source Database Conference Europe 2017, taking place September 25-27, 2017 at the Radisson Blu Royal Hotel in Dublin, Ireland. The special Early Bird registration discount rate is onl y available until August 8, 2017, and a special room rate at the Radisson Blu Royal Hotel expires on August 14, 2017. Sponsorship opportunities are still available.
The Percona Live Open Source Database Conference Europe, which was completely sold-out in 2016, is the premier event for individuals and businesses developing and using open source software.
The conference theme this year is "Championing Open Source Databases," with sessions on MySQL, MariaDB, MongoDB and other open source database technologies, including time series databases, PostgreSQL and RocksDB. The 2017 conference will feature a range of keynote addresses, in-depth discussions and hands-on tutorials for three formal tracks - Developer, Business/Case Studies and Operations.
The full conference schedule will be announced in the coming weeks, but the list of speakers and topics is already impressive, with representatives from Dropbox, Facebook, Oracle, VMware and more. The roster currently includes the following:
- Geir Hoydalsvik (Oracle)
- Shlomi Noach (GitHub)
- Peter Zaitsev (Percona)
- How to Use MySQL in the Cloud - Lixun Peng (Alibaba Cloud)
- A Quick Tour of MySQL 8.0 Roles - Giuseppe Maxia (VMware)
- Introduction to MySQL InnoDB Cluster - Frederic Descamps (Oracle)
- MySQL Infrastructure Testing Automation at GitHub - Shlomi Noach (GitHub)
- InnoDB Locking Demystified - Jan Lindström (MariaDB)
- Improvements to MongoRocks in 2017 - Mark Callaghan (Facebook)
- Migrating to and Living on RDS/Aurora - Balazs Pocze (Gizmodo)
- High-Performance JSON: PostgreSQL Vs. MongoDB - Wei Shan Ang (GlobalSign), Dominic Dwyer (GlobalSign)
- Improve MongoDB Replication and Reduce Competition Between User Queries - Xin Liu (Alibaba)
- What's New in CMongo Tencent's Branch of MongoDB - Deyu Kong (Tencent)
Other Open Source Database Topics:
- How to Backup at Petabyte Scale When Every Transaction Counts - Karoly Nagy (Dropbox)
- Database Reliability Engineering: What - Why and How? - Laine Campbell (Fastly)
- Visualize Your Data with Grafana - Daniel Lee (Grafana Labs)
- Automatic Database Management System Tuning Through Large-Scale Machine Learning - Dana Van Aken (Carnegie Mellon University)
- Elasticsearch (R)Evolution - You Know - for Search... - Philipp Krenn (Elastic)
- Hands-On ProxySQL - Rene Cannao (ProxySQL), David Turner (Uber)
- MySQL Operations in Docker - Giuseppe Maxia (VMware)
- Practical Orchestrator Tutorial - Shlomi Noach (GitHub)
Sponsors for Percona Live Open Source Database Conference Europe 2017 are already signing up. Sponsorship offers the opportunity to interact with hundreds of DBAs, sysadmins, developers, CTOs, CEOs, business managers, technology evangelists, solution vendors, and entrepreneurs who typically attend the event. Current sponsors include:
Diamond Sponsor - Continuent
Gold Sponsor - VividCortex
Percona Live Conferences
What: Percona Live Open Source Database Conference Europe 2017
Where: Radisson Blu Royal Hotel, 8 Golden Lane, Dublin, Ireland
When: September 25-27, 2017
With more than 3,000 customers worldwide, Percona is the only company that delivers enterprise-class solutions for both MySQL®, MongoDB® and other open source databases across traditional and cloud-based platforms. The company provides Software, Support, Consulting, and Managed Services to large, well-known global brands such as Cisco Systems, Time Warner Cable, Alcatel-Lucent, Rent the Runway and the BBC, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. Well established as thought leaders, Percona experts author content for the Percona Database Performance Blog and the Percona Live Open Source Database Conferencesdraw attendees and expert technical speakers from around the world. For more information, visit www.percona.com.
Percona®, XtraBackup®, TokuDB® and Fractal Tree® are registered trademarks of Percona LLC or its subsidiaries. All other registered and unregistered trademarks in this document are the sole property of their respective owners.
Company Information Press Contact Brigit Valencia For Percona (360) 597-4516 email@example.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Percona via Globenewswire
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
Nasdaq Welcomes I-AM Capital Acquisition Company (Nasdaq: IAMXU) to The Nasdaq Stock Market17.8.2017 18:50 | Pressemelding
NEW YORK, Aug. 17, 2017 (GLOBE NEWSWIRE) -- I-AM Capital Acquisition Company (Nasdaq:IAMXU), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, celebrated its initial public offering (IPO) on The Nasdaq Stock Market. I-AM Capital's founders, Chief Executive Officer F. Jacob Cherian and Chief Financial Officer Suhel Kanuga, have been focused on investing into India over the last decade, with the distinction of completing the first listed-SPAC investment in India. "Through our keen focus and unique accomplishments in India over the last decade, we have seen our investment thesis bear fruit: India's prominence and rise on the world stage, its distinction as being one of the fastest growing major economies of the world, and its strong vibrant consumer demographics. We believe these factors are aligning well now,
Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency17.8.2017 14:30 | Pressemelding
WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant (MDR) infections, today announced that the Marketing Authorization Application (MAA) for IV eravacycline for the treatment of complicated intra-abdominal infections (cIAI) has been submitted and was validated by the European Medicines Agency (EMA). Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens. The MAA filing is based on data from the phase 3 IGNITE1 clinical trial in which eravacycline was well tolerated and demonstrated statistical non-inferiority to ertapenem using the primary endpoint of clinical response at the test-of-cure (TOC) visit. "The MAA filing represents a significant milestone for Tetraphase as it is our
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules17.8.2017 13:00 | Pressemelding
RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI), indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions RedHill expects to initiate the U.S. promotion of Esomeprazole Strontium DR Capsules 49.3 mg in the coming weeks Esomeprazole Strontium DR Capsules 49.3 mg will be the third commercial GI product to be promoted by RedHill in the U.S. RedHill's GI-focused sales force currently promotes two GI s
Brand Industrial Services Announces Agreement to Acquire Venko Groep BV16.8.2017 19:40 | Pressemelding
Complementary core strengths provide broader range of services for customers KENNESAW, GA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Brand Industrial Services, known as BrandSafway, has signed an agreement to acquire Venko Groep BV, a portfolio company of Mentha Capital. Venko will become a part of the Brand Energy & Infrastructure Services (Brand) group. "We are very pleased to announce the agreement with Venko," said Bill Hayes, President and CEO of BrandSafway. "Our combined customers in Europe will benefit from a broader range of solutions and greater depth of expertise in access, insulation and coatings. Bringing Venko's highly specialized knowledge in coatings to BrandSafway will provide the expertise we need to expand our services in the offshore market worldwide." Based in the Netherlands, with a focus on operations in the North Sea area, Venko is a leading offshore and onshore coatings maintenance provid
Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A16.8.2017 15:38 | Pressemelding
NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, today announced the pivotal expansion of its gene therapy clinical trials for patients with MPS IIIA in the USA, Europe and Australia. "We have completed the necessary regulatory and ethical committee approvals and site initiations in Europe and Australia in order to accelerate enrollment," stated Juan Ruiz, M.D., Ph.D., Abeona's Chief Medical Officer. "We remain very encouraged by the improvements observed in clinically relevant biomarkers post-dosing of ABO-102, including durable reductions in heparan sulfate measured in the CNS, reduction of organ disease pathology, and signals of CNS improvement or stabilization at one-year follow-up in Cohort 1 subjects, and look forward to providing a more fulsome clinical update at important clinical
CallidusCloud Wins Eight Gold Stevies® in the 2017 International Business Awards16.8.2017 14:00 | Pressemelding
CallidusCloud Lead to Money suite recognized as Best B2B New Product of the Year. LeadRocket voted Best New Product or Service of the Year in the Software - Lead Generation Solution category. DUBLIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning, and customer experience solutions, announced today that it was named the winner of eight Gold Stevie® awards in the 2017 International Business Awards. "The eight Stevie® awards earned highlight CallidusCloud's momentum, commitment to excellence, passion for innovation and customer orientation," said Leslie Stretch, president and CEO of CallidusCloud. "They also recognize the benefits that the Lead to Money suite, honored as the Best New Product in Business-to-Business, accrues to its customers in terms of enabling faster, bigger, and more profitable sales." CallidusCloud's Go
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom